(Q46922854)

26 December 2017

title

Reduced cerebral fluoro-L-dopamine uptake in adult patients suffering from phenylketonuria (English)

1 reference

26 December 2017

0 references

1 reference

2

Eugen Mengel

1 reference

26 December 2017

3

Peter Bartenstein

1 reference

26 December 2017

Paul Cumming

10

Paul Cumming

1 reference

26 December 2017

Hans-Georg Buchholz

4

Hans Georg Buchholz

1 reference

26 December 2017

Mathias Schreckenberger

5

Mathias Schreckenberger

1 reference

26 December 2017

Thomas Siessmeier

6

Thomas Siessmeier

1 reference

26 December 2017

author name string

Christian Landvogt

1

1 reference

26 December 2017

Armin Scheurich

7

1 reference

26 December 2017

Reinhold Feldmann

8

1 reference

26 December 2017

Josef Weglage

9

1 reference

26 December 2017

Fred Zepp

11

1 reference

26 December 2017

Kurt Ullrich

12

1 reference

26 December 2017

publication date

31 October 2007

1 reference

26 December 2017

Journal of Cerebral Blood Flow & Metabolism

published in

1 reference

26 December 2017

volume

28

1 reference

26 December 2017

issue

4

1 reference

26 December 2017

page(s)

824-831

1 reference

26 December 2017

Neuropsychological outcome of subjects participating in the PKU adult collaborative study: a preliminary review

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

Executive functioning and speed of processing in phenylketonuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

[3H]DOPA formed from [3H]tyrosine in living rat brain is not committed to dopamine synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

In vivo regulation of DOPA decarboxylase by dopamine receptors in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

Loss of metabolites from monkey striatum during PET with FDOPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

L-Dopa-responsive Parkinson's syndrome in association with phenylketonuria: In vivo dopamine transporter and D2 receptor findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

Dopa decarboxylase activity of the living human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

Plasma phenylalanine concentrations are associated with hepatic iron content in a murine model for phenylketonuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

"Hypotyrosinemia" in phenylketonuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

Studies on phenylalanine and tyrosine hydroxylation by rat brain tyrosine hydroxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

Human phenylalanine hydroxylase gene expression in kidney and other nonhepatic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

Blood-brain barrier phenylalanine transport and individual vulnerability in phenylketonuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

National Institutes of Health Consensus Development Conference Statement: phenylketonuria: screening and management, October 16-18, 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

In vivo effects of high phenylalanine blood levels on Na+,K+-ATPase, Mg2+-ATPase activities and biogenic amine concentrations in phenylketonuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

Striatal kinetic modeling of FDOPA with a cerebellar-derived constraint on the distribution of volume of 30MFD: a PET investigation using non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

Kinetics of neutral amino acid transport across the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

Effects of large neutral amino acid concentrations on 6-[F-18]Fluoro-L-DOPA kinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

Distribution volume of 3-O-methyl-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

Brain kinetics of L-[?-11 C]DOPA in humans studied by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

7 January 2021

Increased neurotransmitter biosynthesis in phenylketonuria induced by phenylalanine restriction or by supplementation of unrestricted diet with large amounts of tyrosine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

7 January 2021

Neurotransmitter positron emission tomographic-studies in adults with phenylketonuria, a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

7 January 2021

Recommendations for protein and amino acid intake in phenylketonuria patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

7 January 2021

Effect of L-dopa on visual evoked potentials and neuropsychological tests in adult phenylketonuria patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600571

7 January 2021

Identifiers

DOI

10.1038/SJ.JCBFM.9600571

1 reference

26 December 2017

PubMed ID

17971791

1 reference

26 December 2017